EE200200254A - Tiasolidiindiooni derivaadid kui suhkurtõvevastased ained - Google Patents

Tiasolidiindiooni derivaadid kui suhkurtõvevastased ained

Info

Publication number
EE200200254A
EE200200254A EEP200200254A EEP200200254A EE200200254A EE 200200254 A EE200200254 A EE 200200254A EE P200200254 A EEP200200254 A EE P200200254A EE P200200254 A EEP200200254 A EE P200200254A EE 200200254 A EE200200254 A EE 200200254A
Authority
EE
Estonia
Prior art keywords
antidiabetic agents
thiazolidinedione derivatives
thiazolidinedione
derivatives
antidiabetic
Prior art date
Application number
EEP200200254A
Other languages
English (en)
Estonian (et)
Inventor
Mourelle Mancini Marisabel
Carlos Del Castillo Nieto Juan
De Ramon Amat Elisabet
Original Assignee
Vita-Invest, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita-Invest, S.A. filed Critical Vita-Invest, S.A.
Publication of EE200200254A publication Critical patent/EE200200254A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
EEP200200254A 1999-11-18 2000-11-15 Tiasolidiindiooni derivaadid kui suhkurtõvevastased ained EE200200254A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902533A ES2156574B1 (es) 1999-11-18 1999-11-18 Nuevos derivados de tiazolidindiona como agentes antidiabeticos
PCT/ES2000/000432 WO2001036416A1 (es) 1999-11-18 2000-11-15 Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Publications (1)

Publication Number Publication Date
EE200200254A true EE200200254A (et) 2003-06-16

Family

ID=8310628

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200254A EE200200254A (et) 1999-11-18 2000-11-15 Tiasolidiindiooni derivaadid kui suhkurtõvevastased ained

Country Status (37)

Country Link
US (1) US7001910B1 (de)
EP (1) EP1231211B1 (de)
JP (1) JP2003514817A (de)
KR (1) KR100518110B1 (de)
CN (1) CN1159314C (de)
AP (1) AP1330A (de)
AR (1) AR031080A1 (de)
AT (1) ATE241622T1 (de)
AU (1) AU770045B2 (de)
BG (1) BG106699A (de)
BR (1) BR0015613A (de)
CA (1) CA2391913A1 (de)
CO (1) CO5261560A1 (de)
CR (1) CR6640A (de)
CZ (1) CZ20021654A3 (de)
DE (1) DE60003072T2 (de)
DK (1) DK1231211T3 (de)
EA (1) EA004301B1 (de)
EE (1) EE200200254A (de)
ES (2) ES2156574B1 (de)
GE (1) GEP20043240B (de)
HR (1) HRP20020426A2 (de)
HU (1) HUP0203478A2 (de)
IL (1) IL149634A0 (de)
IS (1) IS2014B (de)
MA (1) MA26844A1 (de)
MX (1) MXPA02005011A (de)
NO (2) NO20022336L (de)
NZ (1) NZ519264A (de)
OA (1) OA12089A (de)
PE (1) PE20010858A1 (de)
PL (1) PL354877A1 (de)
PT (1) PT1231211E (de)
SK (1) SK6752002A3 (de)
WO (1) WO2001036416A1 (de)
YU (1) YU40202A (de)
ZA (1) ZA200203906B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2174748B1 (es) * 2001-01-31 2003-09-16 Vita Lab Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
US7713983B2 (en) 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US20050014732A1 (en) * 2003-03-14 2005-01-20 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-diabetic agent
US8283354B2 (en) 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
JP5546372B2 (ja) * 2010-06-30 2014-07-09 積水メディカル株式会社 ベンジルヒダントイン化合物の製造法
WO2016184895A1 (en) 2015-05-18 2016-11-24 Institut National De La Sante Et De La Recherche Medicale (Inserm) Means for detecting or measuring a biological activity of a botulinum toxin
US10689374B1 (en) 2019-07-12 2020-06-23 United Arab Emirates University Pyrimidine-thiazolidinone derivatives
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
IL149634A0 (en) 2002-11-10
GEP20043240B (en) 2004-05-25
DE60003072D1 (de) 2003-07-03
HRP20020426A2 (en) 2004-02-29
AU1281501A (en) 2001-05-30
BG106699A (bg) 2003-02-28
NO20022336L (no) 2002-07-09
CN1402724A (zh) 2003-03-12
NO20022379D0 (no) 2002-05-16
MA26844A1 (fr) 2004-12-20
HUP0203478A2 (hu) 2003-02-28
OA12089A (en) 2006-05-04
US7001910B1 (en) 2006-02-21
BR0015613A (pt) 2002-07-23
EP1231211A1 (de) 2002-08-14
NZ519264A (en) 2003-10-31
ES2199878T3 (es) 2004-03-01
AP1330A (en) 2004-11-25
DK1231211T3 (da) 2003-10-27
DE60003072T2 (de) 2004-04-01
IS6386A (is) 2002-05-15
PT1231211E (pt) 2003-09-30
PE20010858A1 (es) 2001-08-22
JP2003514817A (ja) 2003-04-22
CN1159314C (zh) 2004-07-28
ATE241622T1 (de) 2003-06-15
EP1231211B1 (de) 2003-05-28
ZA200203906B (en) 2004-03-26
IS2014B (is) 2005-06-15
CZ20021654A3 (cs) 2002-09-11
WO2001036416A1 (es) 2001-05-25
NO20022336D0 (no) 2002-05-15
EA200200470A1 (ru) 2002-10-31
YU40202A (sh) 2006-01-16
ES2156574A1 (es) 2001-06-16
ES2156574B1 (es) 2002-02-01
CA2391913A1 (en) 2001-05-25
AP2002002512A0 (en) 2002-06-30
CR6640A (es) 2004-03-05
AR031080A1 (es) 2003-09-10
MXPA02005011A (es) 2003-10-14
EA004301B1 (ru) 2004-02-26
KR20020079737A (ko) 2002-10-19
CO5261560A1 (es) 2003-03-31
PL354877A1 (en) 2004-03-08
SK6752002A3 (en) 2002-09-10
AU770045B2 (en) 2004-02-12
KR100518110B1 (ko) 2005-10-04

Similar Documents

Publication Publication Date Title
CY2016002I2 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
EE200200273A (et) Uudsed diabeedivastased agensid
NO20025978L (no) Benzotiazol-derivater
DK1244641T3 (da) Thiazolylamid-derivater
EE200400075A (et) Peroraalsed antidiabeetilised ained
IL146110A0 (en) Thiazolidinedione derivative and its use as antidiabetic
EE200200254A (et) Tiasolidiindiooni derivaadid kui suhkurtõvevastased ained
IL146115A0 (en) Thiazolidinedione derivative and its use as antidiabetic
NO20020565D0 (no) Interleukin-5-hemmende 6-azauracilderivater
GB0026578D0 (en) Heterocyclic derivatives useful as pharmaceutical agents
SI1173436T1 (en) Thiazolidinedione derivative and its use as antidiabetic
PL351115A1 (en) Thiazolidinedione derivative and its use as antidiabetic
DK1196403T3 (da) Antipsykotiske N-aralkylaminer
NO20022682L (no) Heterosykliske derivater
DE69805392D1 (de) Thiazol-Derivate
SI1231211T1 (en) Thiazolidinedione derivatives as antidiabetic agents
NO20031434L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
SI1173434T1 (en) Thiazolidinedione derivative and its use as antidiabetic
DE50009514D1 (de) Oxazolidinon-derivate
IT247736Y1 (it) Divano-letto perfezionato
ES1045263Y (es) Rastrel perfeccionado
ES1043728Y (es) Bisagra perfeccionada